Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits

goro motomura, Takuaki Yamamoto, Keita Miyanishi, Seiya Jingushi, Yukihide Iwamoto

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Objective. To investigate the effects of combination treatment with an anticoagulant (warfarin) plus a lipid-lowering agent (probucol) on the prevention of steroid-induced osteonecrosis (ON) in rabbits. Methods. Adult male Japanese white rabbits were injected once intramuscularly with 20 mg/kg of methylprednisolone acetate into the right gluteus medius muscle. The rabbits were then divided into 4 groups and treated as follows: one group received warfarin plus probucol (WP; n = 25), one received probucol alone (PA; n = 30), one received warfarin alone (WA; n = 26), and one received no treatment (nonprophylactic [NP]; n = 20). Two weeks after the steroid injection, the femora anil humeri were examined hisiopathologically for the presence of ON. The sizes of the bone marrow fat cells were examined morphologically. Hmatologic examinations were performed before and after the steroid injection. Results. The incidence of ON in the WP group (5%) was significantly lower than that observed in the NP group (70%). While the incidence rates of ON in the PA (38%) and WA (33%) groups were also significantly lower than that in the NP group, they were significantly higher than that observed in the WP group. The sizes of the bone marrow fat cells in both the WP (53.5 ± 4.1 μm) and the PA (52.0 ± 5.0 μm) groups were significantly smaller than those in the NP group (60.0 ± 4.0 μm). We also observed a prolongation of the prothrombin time and a reduction in the plasma lipid levels in the WP group during the study. Conclusion. This study experimentally confirmed that the combined use of an anticoagulant and a lipid-lowering agent helps prevent steroid-induced ON in rabbits.

Original languageEnglish
Pages (from-to)3387-3391
Number of pages5
JournalArthritis and rheumatism
Volume50
Issue number10
DOIs
Publication statusPublished - Oct 1 2004

Fingerprint

Osteonecrosis
Anticoagulants
Probucol
Steroids
Rabbits
Lipids
Warfarin
Adipocytes
Bone Marrow Cells
Injections
Prothrombin Time
Humerus
Incidence
Femur
Muscles
Therapeutics

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Cite this

Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. / motomura, goro; Yamamoto, Takuaki; Miyanishi, Keita; Jingushi, Seiya; Iwamoto, Yukihide.

In: Arthritis and rheumatism, Vol. 50, No. 10, 01.10.2004, p. 3387-3391.

Research output: Contribution to journalArticle

motomura, goro ; Yamamoto, Takuaki ; Miyanishi, Keita ; Jingushi, Seiya ; Iwamoto, Yukihide. / Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. In: Arthritis and rheumatism. 2004 ; Vol. 50, No. 10. pp. 3387-3391.
@article{035f04530b28495dbdd74fb2abf4b9b5,
title = "Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits",
abstract = "Objective. To investigate the effects of combination treatment with an anticoagulant (warfarin) plus a lipid-lowering agent (probucol) on the prevention of steroid-induced osteonecrosis (ON) in rabbits. Methods. Adult male Japanese white rabbits were injected once intramuscularly with 20 mg/kg of methylprednisolone acetate into the right gluteus medius muscle. The rabbits were then divided into 4 groups and treated as follows: one group received warfarin plus probucol (WP; n = 25), one received probucol alone (PA; n = 30), one received warfarin alone (WA; n = 26), and one received no treatment (nonprophylactic [NP]; n = 20). Two weeks after the steroid injection, the femora anil humeri were examined hisiopathologically for the presence of ON. The sizes of the bone marrow fat cells were examined morphologically. Hmatologic examinations were performed before and after the steroid injection. Results. The incidence of ON in the WP group (5{\%}) was significantly lower than that observed in the NP group (70{\%}). While the incidence rates of ON in the PA (38{\%}) and WA (33{\%}) groups were also significantly lower than that in the NP group, they were significantly higher than that observed in the WP group. The sizes of the bone marrow fat cells in both the WP (53.5 ± 4.1 μm) and the PA (52.0 ± 5.0 μm) groups were significantly smaller than those in the NP group (60.0 ± 4.0 μm). We also observed a prolongation of the prothrombin time and a reduction in the plasma lipid levels in the WP group during the study. Conclusion. This study experimentally confirmed that the combined use of an anticoagulant and a lipid-lowering agent helps prevent steroid-induced ON in rabbits.",
author = "goro motomura and Takuaki Yamamoto and Keita Miyanishi and Seiya Jingushi and Yukihide Iwamoto",
year = "2004",
month = "10",
day = "1",
doi = "10.1002/art.20517",
language = "English",
volume = "50",
pages = "3387--3391",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits

AU - motomura, goro

AU - Yamamoto, Takuaki

AU - Miyanishi, Keita

AU - Jingushi, Seiya

AU - Iwamoto, Yukihide

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Objective. To investigate the effects of combination treatment with an anticoagulant (warfarin) plus a lipid-lowering agent (probucol) on the prevention of steroid-induced osteonecrosis (ON) in rabbits. Methods. Adult male Japanese white rabbits were injected once intramuscularly with 20 mg/kg of methylprednisolone acetate into the right gluteus medius muscle. The rabbits were then divided into 4 groups and treated as follows: one group received warfarin plus probucol (WP; n = 25), one received probucol alone (PA; n = 30), one received warfarin alone (WA; n = 26), and one received no treatment (nonprophylactic [NP]; n = 20). Two weeks after the steroid injection, the femora anil humeri were examined hisiopathologically for the presence of ON. The sizes of the bone marrow fat cells were examined morphologically. Hmatologic examinations were performed before and after the steroid injection. Results. The incidence of ON in the WP group (5%) was significantly lower than that observed in the NP group (70%). While the incidence rates of ON in the PA (38%) and WA (33%) groups were also significantly lower than that in the NP group, they were significantly higher than that observed in the WP group. The sizes of the bone marrow fat cells in both the WP (53.5 ± 4.1 μm) and the PA (52.0 ± 5.0 μm) groups were significantly smaller than those in the NP group (60.0 ± 4.0 μm). We also observed a prolongation of the prothrombin time and a reduction in the plasma lipid levels in the WP group during the study. Conclusion. This study experimentally confirmed that the combined use of an anticoagulant and a lipid-lowering agent helps prevent steroid-induced ON in rabbits.

AB - Objective. To investigate the effects of combination treatment with an anticoagulant (warfarin) plus a lipid-lowering agent (probucol) on the prevention of steroid-induced osteonecrosis (ON) in rabbits. Methods. Adult male Japanese white rabbits were injected once intramuscularly with 20 mg/kg of methylprednisolone acetate into the right gluteus medius muscle. The rabbits were then divided into 4 groups and treated as follows: one group received warfarin plus probucol (WP; n = 25), one received probucol alone (PA; n = 30), one received warfarin alone (WA; n = 26), and one received no treatment (nonprophylactic [NP]; n = 20). Two weeks after the steroid injection, the femora anil humeri were examined hisiopathologically for the presence of ON. The sizes of the bone marrow fat cells were examined morphologically. Hmatologic examinations were performed before and after the steroid injection. Results. The incidence of ON in the WP group (5%) was significantly lower than that observed in the NP group (70%). While the incidence rates of ON in the PA (38%) and WA (33%) groups were also significantly lower than that in the NP group, they were significantly higher than that observed in the WP group. The sizes of the bone marrow fat cells in both the WP (53.5 ± 4.1 μm) and the PA (52.0 ± 5.0 μm) groups were significantly smaller than those in the NP group (60.0 ± 4.0 μm). We also observed a prolongation of the prothrombin time and a reduction in the plasma lipid levels in the WP group during the study. Conclusion. This study experimentally confirmed that the combined use of an anticoagulant and a lipid-lowering agent helps prevent steroid-induced ON in rabbits.

UR - http://www.scopus.com/inward/record.url?scp=5644293137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5644293137&partnerID=8YFLogxK

U2 - 10.1002/art.20517

DO - 10.1002/art.20517

M3 - Article

VL - 50

SP - 3387

EP - 3391

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 10

ER -